文献速递乳腺癌

间充质干细胞对顺铂诱导乳腺癌细胞凋亡的影响

[Effect of mesenchymal stem cells on the apoptosis of breast cancer cells induced by cisplatin].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

本研究分离培养乳腺癌来源间质干细胞(BC-MSCs)与癌旁来源间质干细胞(BN-MSCs),用其条件培养基与顺铂共同处理MCF-7细胞。结果显示BC-MSCs较BN-MSCs更明显地降低顺铂对MCF-7的增殖抑制率和凋亡率、提高细胞活力,且与其分泌的白细胞介素6(IL-6)相关。

要点

  • BC-MSCs条件培养基使顺铂对MCF-7的增殖抑制率低于单用顺铂组(P<0.05)。
  • BC-MSCs组MCF-7凋亡率(29.20±2.12)%低于顺铂组(47.77±1.98)%(P<0.05)。
  • BC-MSCs组IL-6水平为BN-MSCs组的(2.50±0.68)倍,加入IL-6中和抗体后凋亡率升高。

核心结论

  • 成功分离培养BC-MSCs和BN-MSCs;与BN-MSCs比较,BC-MSCs能减弱顺铂对MCF-7细胞的作用,显著减少凋亡、促进增殖与活力,且与IL-6相关。

研究设计与样本

  • 体外细胞实验:组织贴壁法分离培养BC-MSCs和BN-MSCs,流式细胞术检测表面标记,成骨成脂诱导检测分化能力。
  • 收集BC-MSCs和BN-MSCs培养48小时的上清液,与顺铂共同处理人乳腺癌MCF-7细胞。
  • MTT法检测增殖抑制率,MUSE细胞分析仪检测凋亡与活力,Luminex液态芯片检测上清IL-6,RT-PCR检测MCF-7细胞IL-6 mRNA。

主要发现

  • 2.5、5、10、20、40、80 μmol/L顺铂作用48小时后,顺铂组MCF-7增殖抑制率分别为(17.33±2.00)%、(22.37±0.73)%、(30.77±1.23)%、(44.93±1.27)%、(62.03±1.97)%和(73.93±1.10)%。
  • 同浓度下,顺铂+BC-MSCs组增殖抑制率分别为(8.27±0.63)%、(11.50±1.30)%、(20.57±0.93)%、(32.60±1.90)%、(52.27±0.73)%和(62.13±2.17)%,低于顺铂组(P<0.05)。
  • 顺铂+BN-MSCs组增殖抑制率分别为(12.90±1.60)%、(16.53±2.87)%、(25.90±1.50)%、(39.40±2.40)%、(57.40±0.70)%和(69.03±1.07)%。
  • 顺铂组、顺铂+BC-MSCs组、顺铂+BN-MSCs组MCF-7凋亡率分别为(47.77±1.98)%、(29.20±2.12)%和(37.92±2.21)%,顺铂+BC-MSCs组低于顺铂组(P<0.05)。
  • 顺铂组、顺铂+BC-MSCs组、顺铂+BN-MSCs组细胞活力分别为0.52±0.02、0.72±0.02和0.64±0.02,顺铂+BC-MSCs组高于顺铂组(P<0.05)。

关键数值与推荐

  • BC-MSCs组IL-6水平为BN-MSCs组的(2.50±0.68)倍(P<0.05)。
  • 顺铂组与顺铂+BC-MSCs组MCF-7细胞IL-6 mRNA相对表达量分别为1.02±0.10和7.58±0.55(P<0.01)。
  • 顺铂+BC-MSCs组与顺铂+BC-MSCs+IL-6中和抗体组凋亡率分别为(27.41±1.95)%和(42.45±2.87)%(P<0.05)。
  • 顺铂+BC-MSCs组与顺铂+BC-MSCs+IL-6中和抗体组细胞活力分别为(72.40±2.60)%和(59.76±3.89)%(P<0.05)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of mesenchymal stem cells (MSCs) on apoptosis of breast cancer cell line MCF-7 induced by cisplatin (DDP), MSCs derived from breast cancer (BC-MSCs) or adjacent non-cancerous tissues (BN-MSCs) were isolated, cultured and identified. Methods: BC-MSCs and BN-MSCs were isolated and cultured by tissue adherent method. The differentiation potential of BC-MSCs was detected by osteogenic and adipogenic induction, and cell surface markers of BC-MSCs and BN-MSCs were evaluated by flow cytometry. MCF-7 cells were co-treated with DDP and conditioned medium (CM) collected from BC-MSCs and BN-MSCs after being cultured for 48 hours, respectively. Inhibition rate of cell proliferation was evaluated by MTT. Cell apoptosis and viability were detected by MUSE cell analyzer. Cytokines in MSC-CM were detected by Luminex liquid chip. Interleukin 6 (IL-6) mRNA expressions in MCF-7 cells with different treatment were detected by RT-PCR. Results: The morphology of BC-MSCs and BN-MSCs successfully isolated and cultured was uniform fibroblast-like clusters under the microscope. These cells expressed high levels of CD29 and CD44, but neither CD14 nor CD34 were detected. MSCs could also differentiate into osteoblasts and adipocytes after specific induction. After treatment with 2.5, 5, 10, 20, 40 and 80 μmol/L DDP, the inhibitory rates of proliferation of MCF-7 cells in DDP group were (17.33±2.00)%, (22.37±0.73)%, (30.77±1.23)%, (44.93±1.27)%, (62.03 ±1.97)% and (73.93±1.10)%, respectively. While the inhibitory rates of DDP+ BC-MSCs group were (8.27±0.63)%, (11.50±1.30)%, (20.57±0.93)%, (32.60 ±1.90)%, (52.27±0.73)% and (62.13±2.17)%, respectively. The inhibitory rates of DDP+ BN-MSCs group were (12.90±1.60)%, (16.53±2.87)%, (25.90±1.50)%, (39.40±2.40)%, (57.40±0.70)% and (69.03±1.07)%, respectively. The inhibitory rates of DDP+ BC-MSCs group were significantly lower than those of DDP group (P<0.05). The apoptotic rates of MCF-7 cells in DDP group, DDP+ BC-MSCs group and DDP+ BN-MSCs group were (47.77±1.98)%, (29.20±2.12)% and (37.92±2.21)%, respectively. The apoptotic rates of DDP group was significantly higher than that of DDP+ BC-MSCs group (P<0.05). The cell viabilities of MCF-7 in DDP group, DDP+ BC-MSCs group and DDP+ BN-MSCs group were 0.52±0.02, 0.72±0.02 and 0.64±0.02, respectively. The cell viability of DDP group was significantly lower than that of DDP+ BC-MSCs group (P<0.05). The result of Luminex liquid chip analysis showed that, the level of IL-6 in BC-MSCs group increased 2.50±0.68 fold when compared with BN-MSCs group (P<0.05). The relative expressions of IL-6 mRNA in DDP group and DDP+ BC-MSCs group were 1.02±0.10 and 7.58±0.55, respectively, with a statistically significant difference (P<0.01). The apoptotic rates of MCF-7 cells in DDP+ BC-MSCs group with or without IL-6 neutralizing antibody were (27.41±1.95)% and (42.45±2.87)%, respectively, with a statistically significant difference (P<0.05). The cell viabilities of MCF-7 cells in DDP+ BC-MSCs group with or without IL-6 neutralizing antibody were (72.40±2.60)% and (59.76±3.89)%, respectively, with a statistically significant difference (P<0.05). Conclusions: BC-MSCs and BN-MSCs have been isolated and cultured successfully. Compared with BN-MSCs, BC-MSCs could attenuate the effect of DDP on MCF-7 cells, evidently decrease the apoptosis and increase the proliferation and vitality in an IL-6 dependent manner. 目的: 分离、培养、鉴定乳腺癌来源间质干细胞(BC-MSCs)及癌旁组织来源间质干细胞(BN-MSCs),探讨其对顺铂(DDP)诱导的人乳腺癌MCF-7细胞凋亡的影响。 方法: 采用组织贴壁法分离培养BC-MSCs和BN-MSCs,成骨、成脂诱导法检测BC-MSCs的分化能力,流式细胞术检测BC-MSCs和BN-MSCs的表面标记。收集BC-MSCs和BN-MSCs 48 h培养上清液,分别与DDP共同处理MCF-7细胞,四甲基偶氮唑蓝(MTT)实验检测不同处理组MCF-7细胞增殖抑制率,Muse全能细胞分析仪检测MCF-7细胞凋亡和活力情况,Luminex液态芯片技术检测MSCs培养上清中白细胞介素6(IL-6)水平,逆转录聚合酶链反应(RT-PCR)检测不同处理组MCF-7细胞中IL-6 mRNA的表达水平。 结果: 成功分离培养出BC-MSCs和BN-MSCs,镜下呈纤维样长梭形,高表达CD29、CD44,不表达CD14、CD34,诱导后可分化为脂肪细胞和成骨细胞。2.5、5、10、20、40、80 μmol/L DDP作用MCF-7细胞48 h后,DDP组的细胞抑制率分别为(17.33±2.00)%、(22.37±0.73)%、(30.77±1.23)%、(44.93±1.27)%、(62.03±1.97)%和(73.93±1.10)%, DDP+BC-MSCs组的细胞抑制率分别为(8.27±0.63)%、(11.50±1.30)%、(20.57±0.93)%、(32.60±1.90)%、(52.27±0.73)%和(62.13±2.17)%, DDP+BN-MSCs组的细胞抑制率分别为(12.90±1.60)%、(16.53±2.87)%、(25.90±1.50)%、(39.40±2.40)%、(57.40±0.70)%和(69.03±1.07)%, DDP+BC-MSCs组的细胞抑制率明显低于DDP组,差异有统计学意义(P<0.05)。DDP组、DDP+BC-MSCs组和DDP+BN-MSCs组的细胞凋亡率分别为(47.77±1.98)%、(29.20±2.12)%和(37.92±2.21)%,DDP+BC-MSCs组与DDP组差异有统计学意义(P<0.05)。DDP组、DDP+BC-MSCs组和DDP+BN-MSCs组的细胞活力比值分别为0.52±0.02、0.72±0.02和0.64±0.02,DDP+BC-MSCs组与DDP组差异有统计学意义(P<0.05)。Luminex液态芯片分析结果显示,BC-MSCs组的IL-6水平是BN-MSCs组的(2.50±0.68)倍,差异有统计学意义(P<0.05)。DDP组和DDP+BC-MSCs组的IL-6 mRNA相对表达量分别为1.02±0.10和7.58±0.55,差异有统计学意义(P<0.01)。DDP+BC-MSCs组和DDP+BC-MSCs+IL-6中和抗体组的细胞凋亡率分别为(27.41±1.95)%和(42.45±2.87)%,差异有统计学意义(P<0.05)。DDP+BC-MSCs组和DDP+BC-MSCs+IL-6中和抗体组的细胞活力分别为(72.40± 2.60)%和(59.76±3.89)%,差异有统计学意义(P<0.05)。 结论: 成功地分离、培养出BC-MSCs和BN-MSCs。与BN-MSCs比较,BC-MSCs能够改善DDP对MCF-7细胞的作用,显著减少DDP诱导MCF-7细胞的凋亡,促进增殖与活力,且与其分泌的IL-6有关。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xu HT, Zhou Y, Li W, et al. [Effect of mesenchymal stem cells on the apoptosis of breast cancer cells induced by cisplatin]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28835077. doi:10.3760/cma.j.issn.0253-3766.2017.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。